EAACI Congress 2025
BackFT11 - Biologics and airway disease in pediatric care
Saturday 14 Jun, 15:00 PM -
16:30 PM Glasgow, United Kingdom
Dochart 2
Flash Talks
15:00
Dupilumab Reduces Exacerbations and Improves Asthma Control in Children With Moderate-to-Severe Type 2 Asthma, Regardless of Asthma Duration
15:07
Dupilumab Reduces Seasonal Exacerbation Rates in Children With Type 2 Asthma With or Without Evidence of Allergy
15:14
Study on the target level and influencing factors of dupilumab treatment in children with moderate to severe atopic dermatitis
15:21
The effect of the community of residence on Wheeze/ asthma symptoms mediated through environmental risk factors and respiratory infection in children in southern Nigeria
15:28
The Hints to Differentiate CAPs From Acute/Recurrent Acute Urticaria: A Multicenter Study
15:35
Is Chronic Rhinosinusitis Still an Underestimated Disease?
15:42
Breath of life: The association between serum pentraxin-3 and respiratory functions in preschool wheezy children
15:49
Evaluation of Asthma Course in Patients Hospitalized in Pediatric Intensive Care Unit Due to Severe Asthma Exacerbation
15:56
How Food Allergen Sensitization Influences Asthma in Children with Atopic Dermatitis
16:03
Untargeted metabolomics reveals the metabolic profiles of children with allergic asthma in eastern and western China
16:10
Carboxylic Acid Metabolism and Key Biomarkers in Airway Allergic Diseases
16:17
Evaluation of Inflammation and Lung Function in Asthmatic Children with Allergic Rhinitis: Comparison of Exhaled Nitric Oxide and Spirometry Measurements
